Clinical Trial: Allogeneic SCT of CordIn™, in Patients With Hemoglobinopathies

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Allogeneic Stem Cell Transplantation of CordIn™, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies

Brief Summary: CordIn™ is a cryopreserved stem/progenitor cell-based product of purified CD133+ cells composed of ex vivo expanded allogeneic UCB cells. The overall study objectives are to evaluate the safety and efficacy of CordIn™.